Healthcare -
Biotechnology - NASDAQ - US
$ 5.235
-1.97 %
$ 1.59 B
Market Cap
52.35
P/E
MNKD - COST OF REVENUE
Cost of Revenue MNKD - MannKind Corporation
62.8 M
LAST VALUE
27.10%
2 YEAR CAGR
25.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR